chart, page-69

It`s all about the scaffold, the work being done by Stratatech is on a collagen scaffold. That may put Polynovo and Dr Greenwood at an advantage in the development of CCS at least from a cost perspective and from the BTM results efficacy as well. What this BARDA contract shows is the amount of money that is being directed at artificial skin.$47.2mUS is more than market cap of CZD

From the Stratatech website

"The Company’s human tissue products are manufactured in a robust, highly reproducible process. In simplified terms, a dermal layer is formed by plating a mixture of collagen and fibroblast cells using standard tissue culture techniques"